Foresee Pharmaceuticals Co. Ltd., of Taipei, Taiwan, appointed Yisheng Lee chief medical officer, and David Lau senior vice president, NCE preclinical and clinical development. Lee will work on establishing Foresee’s strategies related to portfolio management, clinical trials, regulatory affairs, pharmacovigilance and risk management.